Open Access<p>Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews</p>
Author(s) -
Lauren J. Lee,
C.S. Kwon,
A. Forsythe,
Carla Mamolo,
Elizabeth T. Masters,
Ira Jacobs
Publication year - 2020
Publication title -
clinicoeconomics and outcomes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.591
H-Index - 27
ISSN - 1178-6981
DOI - 10.2147/ceor.s274951
Subject(s) - medicine , bladder cancer , systematic review , lower urinary tract symptoms , disease , malignancy , population , economic evaluation , health care , medline , intensive care medicine , cancer , pathology , political science , law , economics , prostate , environmental health , economic growth
Non-muscle invasive bladder cancer (NMIBC) is a malignancy restricted to the inner lining of the bladder. Intravesical Bacillus Calmette-Guerin (BCG) following transurethral resection of the bladder tumor is the mainstay first-line treatment for high-risk NMIBC patients. Two systematic literature reviews (SLRs) were conducted to further assess the current evidence on BCG use in NMIBC and the humanistic and economic burden of disease.